Toronto Dominion Bank
SER icon

Toronto Dominion Bank’s Serina Therapeutics SER Stock Holding History

Toronto Dominion Bank’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,554
Closed -$21.9K – 2132
2025
Q2 		$21.9K Hold
3,554
– – ﹤0.01% 1565
2025
Q1 		$20.2K Buy
+3,554
New +$16.8K ﹤0.01% 1434

Other funds holding SER

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
WA
Waverly Advisors Birmingham, Alabama $13.4B AUM 18.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LW
Linscomb Wealth Houston, Texas $2.25B AUM 23.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
KP
Keel Point Huntsville, Alabama $1.51B AUM 20.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Toronto Dominion Bank's SER Position: Q3 2025 in Review

Toronto Dominion Bank sold out of Serina Therapeutics (SER) in Q3 2025, closing a stake of 3,554 shares — an estimated $21.9K sold.

Toronto Dominion Bank first reported a position in SER in Q1 2025 and held it in 2 quarters. The position peaked at $21.9K in Q2 2025. 25 funds tracked by Wall St. Rank hold SER as of Q3 2025.

  • Toronto Dominion Bank reported no remaining Serina Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Toronto Dominion Bank sold 3,554 Serina Therapeutics shares in Q3 2025, an estimated $21.9K.
  • Toronto Dominion Bank first reported a position in Serina Therapeutics in Q1 2025 and held it in 2 quarters.
  • Toronto Dominion Bank's Serina Therapeutics position peaked at $21.9K in Q2 2025.
  • 25 funds tracked by Wall St. Rank held Serina Therapeutics as of Q3 2025.

Based on Toronto Dominion Bank's 13F filing for Q3 2025, filed 14 Nov 2025.